Gene · 3021
Papers1,611
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
61 to 80 of 1,611
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Molecular pathological insights into tumorigenesis and progression of giant cell tumor of bone. | J Bone Oncol | 2025 | 40092569 | PubTator, text mining | PubMed |
| Mitofusin 1 Drives Preimplantation Development by Enhancing Chromatin Incorporation of Histone H3.3. | Adv Sci (Weinh) | 2025 | 40091361 | PubTator, text mining | PubMed |
| SeqBMC: Single-cell data processing using iterative block matrix completion algorithm based on matrix factorisation. | IET Syst Biol | 2025 | 39943646 | PubTator, text mining | PubMed |
| Histone bivalency in CNS development. | Genes Dev | 2025 | 39880657 | PubTator, text mining | PubMed |
| Exploring PANoptosis Related Novel Diagnostic Biomarkers and Potential Drugs for Sarcopenia based on Machine Learning and Experimental Validation. | Curr Med Chem | 2025 | 39838688 | PubTator, text mining | PubMed |
| Phosphorylation of endothelial histone H3.3 serine 31 by PKN1 links flow-induced signaling to proatherogenic gene expression. | Nat Cardiovasc Res | 2025 | 39779823 | PubTator, text mining | PubMed |
| The histone H3.3 K27M mutation suppresses Ser31phosphorylation and mitotic fidelity, which can directly drive gliomagenesis. | Curr Biol | 2025 | 39729988 | PubTator, text mining | PubMed |
| A novel iPSC model of Bryant-Li-Bhoj neurodevelopmental/neurodegenerative syndrome demonstrates the role of histone H3.3 in chromatin dynamics, neuronal differentiation, and maturation. | bioRxiv | 2025 | 39253491 | PubTator, text mining | PubMed |
| Unravelling the molecular mechanistic pathway underlying the anticancer effects of kaempferol in colorectal cancer: a reverse pharmacology network approach. | Mol Divers | 2025 | 38795259 | PubTator, text mining | PubMed |
| Significance of Biogenetic Markers in Giant Cell Tumor Differentiation and Prognosis: A Narrative Review. | Diagnostics (Basel) | 2024 | 39795567 | PubTator, text mining | PubMed |
| Epigenetic control of myogenic identity of human muscle stem cells in Duchenne muscular dystrophy. | iScience | 2024 | 39650736 | PubTator, text mining | PubMed |
| Neonatal myoclonus in Bryant-Li-Bhoj syndrome associated with a novel H3F3A variant. | Hum Genome Var | 2024 | 39627236 | PubTator, text mining | PubMed |
| An E2 ubiquitin-conjugating enzyme links diubiquitinated H2B to H3K27M oncohistone function. | Proc Natl Acad Sci U S A | 2024 | 39560642 | PubTator, text mining | PubMed |
| Trapping of yFACT at 3' ends of genes is not a universal characteristic of yeast versions of Bryant-Li-Bhoj syndrome histone H3 mutants. | MicroPubl Biol | 2024 | 39525290 | PubTator, text mining | PubMed |
| The H3.3K36M oncohistone disrupts the establishment of epigenetic memory through loss of DNA methylation. | Mol Cell | 2024 | 39368466 | PubTator, text mining | PubMed |
| Structural biology of shelterin and telomeric chromatin: the pieces and an unfinished puzzle. | Biochem Soc Trans | 2024 | 39109533 | PubTator, text mining | PubMed |
| Predicting recurrent glioblastoma clinical outcome to immune checkpoint inhibition and low-dose bevacizumab with tumor in situ fluid circulating tumor DNA analysis. | Cancer Immunol Immunother | 2024 | 39105794 | PubTator, text mining | PubMed |
| HIRA complex deposition of histone H3.3 is driven by histone tetramerization and histone-DNA binding. | J Biol Chem | 2024 | 39059488 | PubTator, text mining | PubMed |
| Exploring liquid-liquid phase separation-related diagnostic biomarkers in osteoarthritis based on machine learning algorithms and experiment. | Immunobiology | 2024 | 38997894 | PubTator, text mining | PubMed |
| Histone H3.3 chaperone HIRA renders stress-responsive genes poised for prospective lethal stresses in acquired tolerance. | Genes Cells | 2024 | 38977420 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3021/papers?page=4